Cardinal Capital Management Inc (North Carolina)’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-12,636
Closed -$219K 136
2023
Q3
$219K Buy
12,636
+565
+5% +$11.8K 0.04% 137
2023
Q2
$251K Buy
12,071
+375
+3% +$8.15K 0.05% 136
2023
Q1
$275K Buy
11,696
+1,077
+10% +$28.9K 0.06% 136
2022
Q4
$297K Buy
10,619
+283
+3% +$7.24K 0.06% 136
2022
Q3
$242K Buy
10,336
+952
+10% +$28.7K 0.06% 138
2022
Q2
$317K Buy
9,384
+721
+8% +$25.3K 0.07% 139
2022
Q1
$303K Buy
8,663
+1,411
+19% +$48.3K 0.06% 140
2021
Q4
$221K Buy
7,252
+219
+3% +$7.13K 0.04% 139
2021
Q3
$231K Buy
7,033
+295
+4% +$9.44K 0.05% 138
2021
Q2
$204K Buy
+6,738
New +$222K 0.04% 140

Other funds holding OGN

Cardinal Capital Management Inc (North Carolina)'s OGN Position: Q4 2023 in Review

Cardinal Capital Management Inc (North Carolina) sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 12,636 shares — an estimated $219K sold.

Cardinal Capital Management Inc (North Carolina) first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $317K in Q2 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Cardinal Capital Management Inc (North Carolina) reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Cardinal Capital Management Inc (North Carolina) sold 12,636 Organon & Co shares in Q4 2023, an estimated $219K.
  • Cardinal Capital Management Inc (North Carolina) first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
  • Cardinal Capital Management Inc (North Carolina)'s Organon & Co position peaked at $317K in Q2 2022.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q4 2023, filed 29 Jan 2024.